These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8923114)

  • 21. Reversible monoamine oxidase-A inhibitors in social phobia.
    Liebowitz MR; Schneier F; Gitow A; Feerick J
    Clin Neuropharmacol; 1993; 16 Suppl 2():S83-8. PubMed ID: 8313403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y; Guelfi JD
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moclobemide: a paradigm of research in clinical psychopharmacology.
    Angst J; Amrein R; Stabl M
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():3-7. PubMed ID: 8923103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moclobemide in social phobia: a pilot open study. GRP Group. Groupe de Recherche en Psychopharmacologie.
    Bisserbe JC; Lépine JP
    Clin Neuropharmacol; 1994; 17 Suppl 1():S88-94. PubMed ID: 7954487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M; Nardi AE; Figueira IL; Stabl M
    Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social phobia: the need for treatment.
    Montgomery SA
    Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S3-9. PubMed ID: 9466168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of social phobia with antidepressants.
    Schneier FR
    J Clin Psychiatry; 2001; 62 Suppl 1():43-8; discussion 49. PubMed ID: 11206033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New uses for antidepressants: social phobia.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1997; 58 Suppl 14():32-6; discussion 37-8. PubMed ID: 9418744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moclobemide--placebo-controlled trials.
    Silverstone T
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide in patients with dementia and depression.
    Amrein R; Martin JR; Cameron AM
    Adv Neurol; 1999; 80():509-19. PubMed ID: 10410765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The offensive subtype of Taijin-kyofu-sho in New York City: the phenomenology and treatment of a social anxiety disorder.
    Clarvit SR; Schneier FR; Liebowitz MR
    J Clin Psychiatry; 1996 Nov; 57(11):523-7. PubMed ID: 8968301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M; Biziére K; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moclobemide in social phobia.
    Duffett R
    Br J Psychiatry; 1998 May; 172():451-2. PubMed ID: 9747419
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia.
    Pétursson H
    Acta Psychiatr Scand Suppl; 1995; 386():36-9. PubMed ID: 7717093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.
    Prasko J; Dockery C; Horácek J; Houbová P; Kosová J; Klaschka J; Pasková B; Praskova H; Seifertová D; Záleský R; Höschl C
    Neuro Endocrinol Lett; 2006 Aug; 27(4):473-81. PubMed ID: 16891998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder.
    Stein DJ; Cameron A; Amrein R; Montgomery SA;
    Int Clin Psychopharmacol; 2002 Jul; 17(4):161-70. PubMed ID: 12131599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
    Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of social phobia with drugs other than benzodiazepines.
    Liebowitz MR; Schneier FR; Hollander E; Welkowitz LA; Saoud JB; Feerick J; Campeas R; Fallon BA; Street L; Gitow A
    J Clin Psychiatry; 1991 Nov; 52 Suppl():10-5. PubMed ID: 1757452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.